Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Iberdomide, Daratumumab, and Dexamethasone (IberDd) in Transplant-Ineligible/Deferred (TNE) Newly Diagnosed Multiple Myeloma (NDMM): Updated Results From the CC-220-MM-001 Trial

MM - 578

Iberdomide, Daratumumab, and Dexamethasone (IberDd) in Transplant-Ineligible/Deferred (TNE) Newly Diagnosed Multiple Myeloma (NDMM): Updated Results From the CC-220-MM-001 Trial

Abdullah Khan

Poster Presenter: Abdullah Khan

Thumbnail for Identification of Predictive Factors for Severe Infections in Multiple Myeloma: A Risk Model Development at a Tertiary Care Center

MM - 919

Identification of Predictive Factors for Severe Infections in Multiple Myeloma: A Risk Model Development at a Tertiary Care Center

Maria Fernanda Montes Rodriguez

Poster Presenter: Maria Fernanda Montes Rodriguez

Previous 1...59 60 61 62 63 64 65...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Identification of RNASEL and ROCK1 as Geometric Bottlenecks in Multiple Myeloma via Discrete Ricci Curvature Analysis

MM - 467

Identification of RNASEL and ROCK1 as Geometric Bottlenecks in Multiple Myeloma via Discrete Ricci Curvature Analysis

Alamin Mustafa

Poster Presenter: Alamin Mustafa

Thumbnail for Identifying Drivers of Patient-Reported Treatment Burden to Inform Symptom Management in Newly Diagnosed Ph+ ALL: Results from the Phase 3 PhALLCON Study

ALL - 514

Identifying Drivers of Patient-Reported Treatment Burden to Inform Symptom Management in Newly Diagnosed Ph+ ALL: Results from the Phase 3 PhALLCON Study

Christopher Dieyi

Poster Presenter: Christopher Dieyi

Thumbnail for IGF2BP1 inhibition impairs PI3K signalling and drives metabolic reprogramming in B-cell acute lymphoblastic leukaemia

ALL - 1707

IGF2BP1 inhibition impairs PI3K signalling and drives metabolic reprogramming in B-cell acute lymphoblastic leukaemia

Ishu Bansal

Poster Presenter: Ishu Bansal

Thumbnail for Immune Cell Type Abundance Predicts Survival of Pediatric Acute Myeloid Leukemia Patients at Diagnosis

AML - 781

Immune Cell Type Abundance Predicts Survival of Pediatric Acute Myeloid Leukemia Patients at Diagnosis

Jaclyn Shaw

Poster Presenter: Jaclyn Shaw

Thumbnail for Immune Checkpoint Inhibitor-Associated Arrhythmias

CT - 321

Immune Checkpoint Inhibitor-Associated Arrhythmias

Soumyadeep Datta

Poster Presenter: Soumyadeep Datta

Thumbnail for Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review

ABCL - 537

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review

Motaz Almahmood

Poster Presenter: Motaz Almahmood

Thumbnail for Immune Effector Cell (IEC)-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome (IEC-HS) in Patients With Hematologic Malignancies: A Systematic Review and Meta-Analysis

CT - 131

Immune Effector Cell (IEC)-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome (IEC-HS) in Patients With Hematologic Malignancies: A Systematic Review and Meta-Analysis

Motaz Almahmood

Poster Presenter: Motaz Almahmood

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors